No overdose data available.
Increased sensitivity to the components of the drug.
Use with caution in children under 4 years old.
Reduces the need for ophthalmic drugs containing glucocorticosteroids.
The transient symptoms of local irritation: impaired visual perception, burning in the eye, conjunctiva edema, a foreign body sensation, dry eyes, lacrimation, barley in the century. The defeat of the epithelium of the cornea.
Allergic conjunctivitis, allergic keratitis, keratoconjunctivitis, irritation of the mucous membrane of the eyes due to allergic reactions (environmental factors, occupational hazards, household chemicals, cosmetics, ophthalmological dosage forms, plant pollen and animal dandruff).
Prevents the degradation of fat cells and the separation of histamine, bradikinin, leukotrienes from them (including.h. slowly responding substance) and other biologically active substances. Most effective in preventive use.
Absorption through the mucous membrane of the eyes is negligible. System bioavailability is less than 0.1%. T1/2 - 5-10 minutes.
Keep out of the reach of children.
Shelf life of the drug Stadaglytsineye drops 20 mg / ml - 3 years. After opening the bottle, use for 4 weeks.
slanging for 20 mg / ml - 3 years.
Do not apply after the expiration date indicated on the package.
| Drops of eye | 1 ml |
| sodium cromoglycate | 20 mg |
| auxiliary substances : 0.1 mg of chloride benzalkonium, 1.5 mg of 2H dynatrium salt2O edetinic acid, sodium chloride, sodium dihydrophosphate dihydrate, sodium monogydrophosphate dodecahydrate, sorbitol, water for injection |
in polyethylene vials of polyethylene 5 or 10 ml; in a cardboard pack of 1 bottle-camera.
| Spray for nasal use | 0.14 ml |
| sodium cromoglycate | 2.8 mg |
| auxiliary substances : 0.014 mg benzalkonia chloride, 0.21 mg of dynatrium salt 2H2O edetinic acid, sodium chloride, sodium dihydrophosphate dihydrate, sodium monogydrophosphate dodecahydrate, sorbitol, water for injection |
in polyethylene bottles of 15 ml; in a pack of cardboard 1 bottle.
Eye drops : conjunctivally. Adults and children over 4 years old - 1 drop in each eye up to 4 times a day.
If it is necessary to use for a long time, treatment is carried out under the supervision of a doctor.
The abolition of the drug should be carried out gradually over 1 week.
Spray for nasal use : intranasally, by introducing the spray hole of the micro-disper into the nose and pressing the spray mechanism.
Adults and children from 5 years old - 1 dose per night 3-4 times a day (1 dose corresponds to one pressure on the spray mechanism).
If necessary, the daily dose is increased, but the frequency of use should not exceed 6 times a day.
Treatment continues until the patient is exposed to allergens (domestic dust, fungal spores, floral pollen, etc.d.).
